Event Schedule

Please note that all events will take place in the BRI-Seminar Room unless otherwise noted.

Registration and Welcome Breakfast

7:00 - 8:00 am

Opening Remarks

8:00 - 8:10 am

8:10-8:20 am

8:20-8:25 am

Karin Hoffmeister, MD, Director of Translational Glycomics Center

Chris Miskel, Versiti, BloodCenter of Wisconsin

Gilbert C. White, II, MD, Blood Research Institute, BloodCenter of Wisconsin, Versiti

Session 1: Glycans in Niche Environments

Session Chairs: M. Lee-Sundlov, PhD; L. Rivadeneyra, PhD

8:25 - 9:15 am

9:15 - 9:30 am

9:30 - 9:45 am

Keynote Lecture: Glycomimetic Drugs that Target the Tumor Microenvironment in Clinical Trials for Hematological Malignancies

John Magnani, PhD, GlycoMimetics, Inc.

Red Blood Cell Glycomics: Past, Present, and Future

Waseem Anani, MD, Associate Medical Director of Transfusion Medicine and Assistant Clinical Professor of Pathology

Aberrant Sialylation and the Pathobiology of Thrombocytopenia

Melissa Lee-Sundlov, PhD, Blood Research Institute, BloodCenter of Wisconsin

9:45 - 10:00 am

Coffee Break

Session 2: Glycans in Blood Disease, and Inflammation

Session Chair: S. Haberichter, PhD ; S. Giannini, PhD

10:00-10:30 am

10:30-11:00 am

11:00-11:15 am

11:15-11:30 am

11:30-11:45 am

11:45- 11:50 am

Glycans in the Bone Marrow Niche

Silvia Giannini, PhD, Brigham and Women’s Hospital

Invited Speaker: Platelets Regulate a Novel Mode of Extracellular Glycosylation

Joseph T.Y. Lau, PhD, Roswell Park Comprehensive Cancer Center

Absence of β-1,4-Galactosyltransferase Severely Affects the Bone Marrow Niche

Leonardo Rivadeneyra, PhD, Blood Research Institute, BloodCenter of Wisconsin

Integrin Function and Glycans

Jieqing Zhu, PhD, Blood Research Institute

Development of an Assay to Determine von Willebrand Factor Glycan Composition

Connie Kwas, MS, Blood Research Institute, BloodCenter of Wisconsin

Poster Presentation

Alicia Eustes, University of Utah

Lunch and Sponsor Exhibition

11:50 - 1:00 pm

BRI - Cafeteria

Session 3: Glycans &Gene Therapy in Pediatric Disease

Session Chairs: M. Burke, MD; N. Dahms, PhD

1:00-1:30 pm

1:30-1:45 pm

1:45-2:00 pm

2:00-2:15 pm

2:15-2:30 pm

2:30-2:45 pm

Treatment Strategies for Globoid Cell Leukodystrophy: Successes and Challenges

Mark Sands, PhD, Washington University School of Medicine in St. Louis

Glycan Changes in Dorsal Root Ganglia are Associated with Fabry Disease Pain

Jimmy Miller, PhD, Medical College of Wisconsin

T Rapa Cells as Delivery Vehicles for α-galactosidase A in Fabry Patients

Murtaza Nagree, Medical College of Wisconsin

Linking Glycans and Reduced Von Willebrand Factor Survival

Sandra Haberichter, PhD, Blood Research Institute, BloodCenter of Wiscosin

ATB200: A Novel rhGAA ERT with Optimized Glycosylation for Improved Therapeutic Efficacy

Russell Gotschall, Amicus Therapeutics

M6PR-specific Targeting of Lysosomal Enzymes Regulates Platelet Production and Function in Mice

Hervé Falet, PhD, Blood Research Institute, BloodCenter of Wisconsin

2:45 - 3:00 pm

Coffee Break

Session 4: Glycosaminoglycans and Mass Spectrometry: The Frontiers in Glycan Investigation

Session Chair: R. Gundry, PhD; W. Anani, PhD

3:00-3:30 pm

3:30-3:45 pm

3:45-4:05 pm

Glycosaminoglycan Specificity – A Pipe Dream?

Umesh Desai, PhD, Virginia Commonwealth University

Glycosaminoglycan Modulation of Chemokine Function

Brian Volkman, PhD, Medical College of Wisconsin

Invited Speaker: Mapping the Cardiomyocyte Surfaceome: New Technologies for Studying Glycoproteins in Differentiation and Disease

Rebekah Gundry, PhD, Medical College of Wisconsin

End Remarks

4:05-4:10 pm

Karin Hoffmeister, MD, Blood Research Institute, BloodCenter of Wisconsin

Poster Session and Networking

4:15-7:00 pm

Joint session with the Mass Spectrometry Research Symposium in the Medical College of Wisconsin – Alumni Center

For information about the Mass Spectrometry Research Symposium, click here!

Google Sites

Report abuse